NCT04718350Completed
Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents
Comparison of Intravenous Levosimendan and Inhalational Milrinone in High Risk Cardiac Patients With Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 22 Jul 2025
Brief summary (registry, in English)
The aim of this study is to examine and compare the effect of Levosimendan and Milrinone administered intravenously and via inhalation respectively in cardiac surgery patients with pulmonary hypertension and right ventricular dysfunction.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 16 Jan 2021
- Start date
- Jan 2021
- Primary completion date
- Dec 2023
- Lead sponsor
- Aretaieion University Hospital
- NCT number
- NCT04718350
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From Jan 2021 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- emergency surgery
- redo surgery
Other illness
- primary pulmonary hypertension
- thromboembolic disease
- chronic obstructive pulmonary disease
Other
- inability to consent to the study
Who the study is looking for
- patients with pulmonary hypertension due to left ventricular dysfunction based on echocardiographic diagnosis preoperatively
- elective cardiac surgery
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Onassis Cardiac Surgery Center Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.